Yes, the president of Moderna did mention the idea of ​​an annual recall against the Covid-19

“Are you all ready to receive your anti-Covid booster doses for the rest of your life?” Moderna’s general manager, Stéphane Bancel, wants to finish you off slowly and get richer! “

For this Twitter user opposed to health measures against Covid-19 – including vaccination -, it is obvious: the boss of one of the pharmaceutical companies concerned has long planned to “make profitable” his product by maximizing the number of injections reminders. He wants as proof the video extract of an interview with Stéphane Bancel by a Quebec journalist, relayed in his tweet.

In this sequence, the French president of the American group Moderna affirms in particular: “It is necessary to see that [le] Covid is not going to go away, it is a virus that we are going to have to live with. But by doing regular reminders, it will be like the flu, we will live with it and very few people will be hospitalized. […] This is Moderna’s commitment: we will continue to make recalls adapted to the variants until this pandemic becomes endemic and therefore it would be just living with one booster per year. “

And Stéphane Bancel to add: “I think we will have to have regular reminders all the rest of our lives, like the flu. […] I think if we want to have a good winter […] a third dose, starting with the people most at risk, who were vaccinated the longest ago, it’s really important to protect as many people as possible. “

FAKE OF F

This extract is authentic: it was broadcast on the Quebec channel LCN on August 24, 2021, when Moderna announced the launch of a factory in Canada.

If concerns around the Delta variant and a possible relaunch of the Covid-19 epidemic were then omnipresent in the world, Stéphane Bancel’s mention of a potential annual vaccine booster was then nothing new nor surprising given the latest scientific knowledge on the virus.

The president of Moderna indeed evoked such a scenario from May 2021 on the BFMTV antenna: “We have to live with it like the flu, we know how to do that very well. So there is a period of a year or two that will be a bit complicated because we are not able to vaccinate the whole planet. […] We are in an interconnected world today […], and therefore we anticipate variants that will return to the northern hemisphere in the fall and next winter and therefore we know that the recalls will of course be very important ”.

The hypothesis of a disease that would become seasonal

At the time, researchers from the University of Utah, in the United States, precisely estimated in a study that Covid-19 could become a seasonal disease within ten years, due to the evolution of collective immunity – the hypothesis of a “trivialization” of the virus having been raised
from March 2021.

On August 25, 2021, the day after Stéphane Bancel’s intervention on LCN, Moderna’s commercial director, Corinne Le Goff, specified for her part on BFMTV : “There is a scenario in which the virus continues to evolve and the level of transmissibility is increasingly important. And in that case, we can consider a booster every year, like the flu shot. “

A generalization of the third dose which is still debated

On October 6, the High Authority for Health (HAS) recommended a third dose of vaccine for “caregivers, medical transporters and professionals in the medico-social sector” as well as for those around immunocompromised people, while a campaign of recall was already underway since September for those over 65 and those at risk, such as diabetics. Objective: to fight against the loss of effectiveness of anti-Covid vaccines over time, despite still high protection against severe forms of the disease.

Even if the circumstances “do not justify, at this stage, to recommend the administration of an additional dose in the general population, (…) the HAS then underlined in its opinion, that the administration of a booster dose will probably become necessary in the coming months ”.

The European Medicines Authority paved the way for this on October 6 by authorizing the generalization of a recall to all adults, leaving the authorities of each country of the European Union the precise choice of the persons concerned. However, the need for such a booster dose is still the subject of much debate in the scientific world, its interest still to be assessed for the entire population.

In addition, this booster dose must for the time being necessarily come from a Pfizer / BioNTech vaccine, based on messenger RNA technology. While it has so far advocated indifferently to resort to Pfizer or Moderna vaccines for booster doses of the anti-Covid-19 vaccine, the High Authority for Health temporarily recommends, as a precautionary principle, no longer using Moderna because of cases of pericarditis and myocarditis which could be more important, especially in the youngest people,
as reported The Parisian.


source site